Certolizumab and anti-Certolizumab antibody
Certolizumab and anti-Certolizumab antibody-994
Certolizumab and anti-Certolizumab antibody
994
LAB994
MSO
Anti-TNF
Anti-TNF drug
Biologic drug level and anti-drug antibody
Biologic monitoring
Cimzia
DoseASSURE
Immunogenicity testing
TDM
TNF inhibitor
Anti-TNF drug
Biologic drug level and anti-drug antibody
Biologic monitoring
Cimzia
DoseASSURE
Immunogenicity testing
TDM
TNF inhibitor
Certolizumab drug level, anti-certolizumab antibodies and serial monitoring
Provides certolizumab drug concentration and anti-certolizumab antibodies in order to optimize treatment and facilitate clinical decision-making. This assay may be helpful in any patient on certolizumab therapy for Crohn's disease, psoriasis, or other autoimmune condition.
Serum
2.0 mL
0.6 mL
Immediately following collection, mix sample by gently inverting 5 times
- Allow sample to clot for a minimum of 30 minutes
- Spin within two (2) hours of sample collection
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
Gold serum separator (SST) tube
- Allow sample to clot
- Spin within two (2) hours of sample collection
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
Refrigerated (preferred) - 14 days
Frozen - 14 days
Freeze/thaw cycles: stable x 6
Ambient - 18 hours
- Gross hemolysis
- Gross lipemia
Esoterix Endocrinology (804627) via LabCorp (504627) : R-NX
Mo
8 - 15 days
Electrochemiluminescence Immunoassay (ECLIA); Surface Plasmon Resonance
An interpretive report will be provided
80299
82397
82397
08/29/2019
12/20/2023
12/20/2023